ArticleAdvances in therapyPublished
FREEDOMM: Fifth-Line or Later Real-World Evaluation of Efficacy and Disease Outcomes in Multiple Myeloma with Ciltacabtagene Autoleucel: Treatment-Free Interval and Overall Survival in the USA
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Advances in therapy
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Treatment Outcome; Aged; Middle Aged; United States; Female; Male; Bridge Therapy; Multiple myeloma; Clinical Outcomes; Overall Survival
- PubMed ID
- 41874852
- PubMed Central ID
- PMC13156228
- Open access
- Yes, open
- Added to directory
- Source checked